Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
WNT SIGNALING PATHWAY |
74 |
351 |
2.574e-101 |
1.198e-97 |
2 |
CANONICAL WNT SIGNALING PATHWAY |
39 |
95 |
8.408e-64 |
1.956e-60 |
3 |
REGULATION OF WNT SIGNALING PATHWAY |
48 |
310 |
6.538e-56 |
1.014e-52 |
4 |
NON CANONICAL WNT SIGNALING PATHWAY |
34 |
140 |
3.034e-46 |
3.529e-43 |
5 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
35 |
197 |
2.04e-42 |
1.898e-39 |
6 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
36 |
236 |
4.028e-41 |
3.123e-38 |
7 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
51 |
1021 |
1.998e-34 |
1.328e-31 |
8 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
28 |
162 |
1.752e-33 |
1.019e-30 |
9 |
BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY |
16 |
22 |
6.262e-32 |
3.237e-29 |
10 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
62 |
1929 |
7.642e-32 |
3.556e-29 |
11 |
REGULATION OF ORGAN MORPHOGENESIS |
30 |
242 |
2.419e-31 |
1.023e-28 |
12 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
57 |
1672 |
3.865e-30 |
1.499e-27 |
13 |
EPITHELIUM DEVELOPMENT |
45 |
945 |
4.023e-29 |
1.44e-26 |
14 |
POSITIVE REGULATION OF GENE EXPRESSION |
56 |
1733 |
2.483e-28 |
8.251e-26 |
15 |
TISSUE MORPHOGENESIS |
36 |
533 |
3.223e-28 |
9.998e-26 |
16 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
48 |
1192 |
5.735e-28 |
1.668e-25 |
17 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
55 |
1710 |
1.213e-27 |
3.321e-25 |
18 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
52 |
1492 |
1.443e-27 |
3.731e-25 |
19 |
TUBE MORPHOGENESIS |
30 |
323 |
1.594e-27 |
3.852e-25 |
20 |
REGULATION OF EMBRYONIC DEVELOPMENT |
22 |
114 |
1.656e-27 |
3.852e-25 |
21 |
MORPHOGENESIS OF AN EPITHELIUM |
32 |
400 |
2.573e-27 |
5.701e-25 |
22 |
POSITIVE REGULATION OF CELL COMMUNICATION |
52 |
1532 |
5.076e-27 |
1.074e-24 |
23 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
49 |
1360 |
1.982e-26 |
4.01e-24 |
24 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
16 |
39 |
2.914e-26 |
5.649e-24 |
25 |
TISSUE DEVELOPMENT |
51 |
1518 |
3.164e-26 |
5.888e-24 |
26 |
ORGAN MORPHOGENESIS |
40 |
841 |
1.174e-25 |
2.101e-23 |
27 |
REGULATION OF CELL DIFFERENTIATION |
50 |
1492 |
1.346e-25 |
2.319e-23 |
28 |
TUBE DEVELOPMENT |
34 |
552 |
2.725e-25 |
4.529e-23 |
29 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
51 |
1618 |
6.018e-25 |
9.656e-23 |
30 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
53 |
1805 |
1.343e-24 |
2.083e-22 |
31 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
20 |
110 |
1.65e-24 |
2.476e-22 |
32 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
33 |
554 |
4.52e-24 |
6.573e-22 |
33 |
EMBRYONIC MORPHOGENESIS |
32 |
539 |
2.756e-23 |
3.886e-21 |
34 |
EMBRYO DEVELOPMENT |
38 |
894 |
1.388e-22 |
1.9e-20 |
35 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
41 |
1135 |
8.255e-22 |
1.097e-19 |
36 |
PATTERN SPECIFICATION PROCESS |
28 |
418 |
8.885e-22 |
1.148e-19 |
37 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
49 |
1791 |
3.569e-21 |
4.488e-19 |
38 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
40 |
1142 |
9.217e-21 |
1.129e-18 |
39 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
35 |
823 |
9.563e-21 |
1.141e-18 |
40 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
30 |
552 |
1.004e-20 |
1.168e-18 |
41 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
38 |
1036 |
2.335e-20 |
2.587e-18 |
42 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
38 |
1036 |
2.335e-20 |
2.587e-18 |
43 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
34 |
788 |
2.46e-20 |
2.602e-18 |
44 |
CIRCULATORY SYSTEM DEVELOPMENT |
34 |
788 |
2.46e-20 |
2.602e-18 |
45 |
REGIONALIZATION |
24 |
311 |
3.782e-20 |
3.911e-18 |
46 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
19 |
152 |
4.412e-20 |
4.463e-18 |
47 |
REGULATION OF BINDING |
23 |
283 |
7.715e-20 |
7.638e-18 |
48 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
25 |
365 |
1.042e-19 |
1.01e-17 |
49 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
18 |
134 |
1.194e-19 |
1.134e-17 |
50 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
36 |
957 |
1.328e-19 |
1.236e-17 |
51 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
20 |
194 |
2.141e-19 |
1.954e-17 |
52 |
INTRACELLULAR SIGNAL TRANSDUCTION |
44 |
1572 |
3.525e-19 |
3.154e-17 |
53 |
NEURON DIFFERENTIATION |
34 |
874 |
6.184e-19 |
5.429e-17 |
54 |
NEURAL TUBE DEVELOPMENT |
18 |
149 |
8.501e-19 |
7.325e-17 |
55 |
REGULATION OF CELL CYCLE |
35 |
949 |
9.026e-19 |
7.636e-17 |
56 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
46 |
1784 |
1.036e-18 |
8.609e-17 |
57 |
GASTRULATION |
18 |
155 |
1.755e-18 |
1.433e-16 |
58 |
NEUROGENESIS |
41 |
1402 |
1.86e-18 |
1.467e-16 |
59 |
TUBE FORMATION |
17 |
129 |
1.834e-18 |
1.467e-16 |
60 |
DORSAL VENTRAL AXIS SPECIFICATION |
10 |
20 |
6.643e-18 |
5.152e-16 |
61 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
37 |
1152 |
6.839e-18 |
5.216e-16 |
62 |
REGULATION OF PROTEIN LOCALIZATION |
34 |
950 |
7.997e-18 |
6.002e-16 |
63 |
NEURAL TUBE FORMATION |
15 |
94 |
1.048e-17 |
7.743e-16 |
64 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE |
9 |
14 |
1.341e-17 |
9.751e-16 |
65 |
CELL DEVELOPMENT |
40 |
1426 |
2.381e-17 |
1.705e-15 |
66 |
REGULATION OF TRANSFERASE ACTIVITY |
33 |
946 |
5.808e-17 |
4.095e-15 |
67 |
REGULATION OF RESPONSE TO STRESS |
40 |
1468 |
6.494e-17 |
4.51e-15 |
68 |
REGULATION OF CELL DEATH |
40 |
1472 |
7.132e-17 |
4.88e-15 |
69 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
39 |
1395 |
7.628e-17 |
5.144e-15 |
70 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
42 |
1656 |
1.08e-16 |
7.181e-15 |
71 |
SENSORY ORGAN DEVELOPMENT |
25 |
493 |
1.323e-16 |
8.672e-15 |
72 |
SEGMENTATION |
14 |
89 |
1.668e-16 |
1.078e-14 |
73 |
REGULATION OF CELLULAR LOCALIZATION |
37 |
1277 |
1.93e-16 |
1.23e-14 |
74 |
CELL PROLIFERATION |
28 |
672 |
2.392e-16 |
1.504e-14 |
75 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
33 |
1004 |
3.319e-16 |
2.059e-14 |
76 |
HEART DEVELOPMENT |
24 |
466 |
4.111e-16 |
2.496e-14 |
77 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
15 |
119 |
4.13e-16 |
2.496e-14 |
78 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
28 |
691 |
4.867e-16 |
2.903e-14 |
79 |
REGULATION OF CELL PROLIFERATION |
39 |
1496 |
7.918e-16 |
4.664e-14 |
80 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
43 |
1848 |
9.241e-16 |
5.375e-14 |
81 |
POSITIVE REGULATION OF CELL DEATH |
26 |
605 |
1.595e-15 |
9.164e-14 |
82 |
CELL FATE COMMITMENT |
18 |
227 |
1.664e-15 |
9.439e-14 |
83 |
SOMITOGENESIS |
12 |
62 |
1.877e-15 |
1.052e-13 |
84 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
29 |
801 |
2.515e-15 |
1.393e-13 |
85 |
PROTEIN PHOSPHORYLATION |
31 |
944 |
3.293e-15 |
1.803e-13 |
86 |
SENSORY ORGAN MORPHOGENESIS |
18 |
239 |
4.112e-15 |
2.225e-13 |
87 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
20 |
323 |
4.688e-15 |
2.507e-13 |
88 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
15 |
142 |
6.098e-15 |
3.224e-13 |
89 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
38 |
1518 |
7.751e-15 |
4.052e-13 |
90 |
REGULATION OF KINASE ACTIVITY |
28 |
776 |
9.055e-15 |
4.682e-13 |
91 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
21 |
381 |
9.19e-15 |
4.699e-13 |
92 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
20 |
337 |
1.051e-14 |
5.314e-13 |
93 |
MACROMOLECULAR COMPLEX DISASSEMBLY |
16 |
182 |
1.352e-14 |
6.762e-13 |
94 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
17 |
220 |
1.644e-14 |
8.139e-13 |
95 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
9 |
26 |
1.972e-14 |
9.659e-13 |
96 |
REGULATION OF CELL CYCLE PROCESS |
24 |
558 |
2.235e-14 |
1.083e-12 |
97 |
EMBRYONIC ORGAN DEVELOPMENT |
21 |
406 |
3.21e-14 |
1.54e-12 |
98 |
REGULATION OF JNK CASCADE |
15 |
159 |
3.329e-14 |
1.581e-12 |
99 |
SOMITE DEVELOPMENT |
12 |
78 |
3.486e-14 |
1.638e-12 |
100 |
DOPAMINERGIC NEURON DIFFERENTIATION |
9 |
28 |
4.316e-14 |
2.008e-12 |
101 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
37 |
1517 |
4.407e-14 |
2.01e-12 |
102 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
15 |
162 |
4.399e-14 |
2.01e-12 |
103 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
16 |
197 |
4.703e-14 |
2.125e-12 |
104 |
REGULATION OF JUN KINASE ACTIVITY |
12 |
81 |
5.593e-14 |
2.502e-12 |
105 |
BETA CATENIN TCF COMPLEX ASSEMBLY |
10 |
43 |
6.149e-14 |
2.725e-12 |
106 |
REGULATION OF TRANSPORT |
40 |
1804 |
6.719e-14 |
2.949e-12 |
107 |
REGULATION OF PROTEIN BINDING |
15 |
168 |
7.553e-14 |
3.285e-12 |
108 |
REGULATION OF CYTOPLASMIC TRANSPORT |
22 |
481 |
8.992e-14 |
3.874e-12 |
109 |
NEGATIVE REGULATION OF GENE EXPRESSION |
36 |
1493 |
1.528e-13 |
6.523e-12 |
110 |
REGULATION OF ORGANELLE ORGANIZATION |
32 |
1178 |
2.041e-13 |
8.631e-12 |
111 |
AXIS SPECIFICATION |
12 |
90 |
2.072e-13 |
8.684e-12 |
112 |
REGULATION OF INTRACELLULAR TRANSPORT |
24 |
621 |
2.283e-13 |
9.485e-12 |
113 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
36 |
1527 |
2.994e-13 |
1.233e-11 |
114 |
REGULATION OF PROTEIN TARGETING |
18 |
307 |
3.11e-13 |
1.269e-11 |
115 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
22 |
513 |
3.287e-13 |
1.33e-11 |
116 |
REGULATION OF CELL DEVELOPMENT |
27 |
836 |
4.152e-13 |
1.666e-11 |
117 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
16 |
228 |
4.569e-13 |
1.817e-11 |
118 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
21 |
470 |
5.503e-13 |
2.17e-11 |
119 |
CELL DEATH |
29 |
1001 |
7.225e-13 |
2.825e-11 |
120 |
CONVERGENT EXTENSION |
7 |
14 |
7.322e-13 |
2.839e-11 |
121 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
30 |
1079 |
7.621e-13 |
2.931e-11 |
122 |
EMBRYONIC ORGAN MORPHOGENESIS |
17 |
279 |
8.031e-13 |
3.063e-11 |
123 |
REGULATION OF HYDROLASE ACTIVITY |
33 |
1327 |
9.048e-13 |
3.423e-11 |
124 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
14 |
167 |
1.279e-12 |
4.8e-11 |
125 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
40 |
1977 |
1.309e-12 |
4.874e-11 |
126 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
25 |
740 |
1.329e-12 |
4.908e-11 |
127 |
REGULATION OF CELL MORPHOGENESIS |
22 |
552 |
1.415e-12 |
5.183e-11 |
128 |
FC RECEPTOR SIGNALING PATHWAY |
15 |
206 |
1.508e-12 |
5.48e-11 |
129 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
19 |
393 |
1.984e-12 |
7.156e-11 |
130 |
RHYTHMIC PROCESS |
17 |
298 |
2.317e-12 |
8.295e-11 |
131 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
8 |
27 |
2.5e-12 |
8.879e-11 |
132 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
33 |
1381 |
2.696e-12 |
9.504e-11 |
133 |
CELLULAR COMPONENT DISASSEMBLY |
21 |
515 |
3.152e-12 |
1.103e-10 |
134 |
REGULATION OF STEM CELL DIFFERENTIATION |
12 |
113 |
3.334e-12 |
1.158e-10 |
135 |
PHOSPHORYLATION |
31 |
1228 |
3.597e-12 |
1.24e-10 |
136 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
10 |
63 |
3.711e-12 |
1.27e-10 |
137 |
HEAD DEVELOPMENT |
24 |
709 |
3.845e-12 |
1.306e-10 |
138 |
CELL CYCLE |
32 |
1316 |
3.988e-12 |
1.345e-10 |
139 |
REGULATION OF PROTEIN IMPORT |
14 |
183 |
4.474e-12 |
1.498e-10 |
140 |
CELL CYCLE PROCESS |
29 |
1081 |
4.808e-12 |
1.598e-10 |
141 |
CELLULAR RESPONSE TO RETINOIC ACID |
10 |
65 |
5.147e-12 |
1.698e-10 |
142 |
MIDBRAIN DEVELOPMENT |
11 |
90 |
5.79e-12 |
1.897e-10 |
143 |
REGULATION OF MAPK CASCADE |
23 |
660 |
6.413e-12 |
2.087e-10 |
144 |
DORSAL VENTRAL PATTERN FORMATION |
11 |
91 |
6.554e-12 |
2.118e-10 |
145 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
25 |
799 |
7.077e-12 |
2.271e-10 |
146 |
MESENCHYME DEVELOPMENT |
14 |
190 |
7.452e-12 |
2.375e-10 |
147 |
DIGESTIVE TRACT MORPHOGENESIS |
9 |
48 |
9.491e-12 |
3.004e-10 |
148 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
22 |
616 |
1.219e-11 |
3.832e-10 |
149 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
24 |
750 |
1.249e-11 |
3.9e-10 |
150 |
POSITIVE REGULATION OF CELL CYCLE |
17 |
332 |
1.293e-11 |
4.012e-10 |
151 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
27 |
983 |
1.78e-11 |
5.486e-10 |
152 |
NEGATIVE REGULATION OF BINDING |
12 |
131 |
1.958e-11 |
5.954e-10 |
153 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
12 |
131 |
1.958e-11 |
5.954e-10 |
154 |
CELL ACTIVATION |
21 |
568 |
1.99e-11 |
6.012e-10 |
155 |
REGULATION OF IMMUNE SYSTEM PROCESS |
32 |
1403 |
2.142e-11 |
6.432e-10 |
156 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
21 |
573 |
2.343e-11 |
6.988e-10 |
157 |
COCHLEA MORPHOGENESIS |
7 |
21 |
2.397e-11 |
7.103e-10 |
158 |
CELLULAR RESPONSE TO LIPID |
19 |
457 |
2.725e-11 |
8.026e-10 |
159 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
12 |
135 |
2.798e-11 |
8.187e-10 |
160 |
HEART MORPHOGENESIS |
14 |
212 |
3.265e-11 |
9.495e-10 |
161 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
18 |
408 |
3.62e-11 |
1.046e-09 |
162 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
15 |
258 |
3.803e-11 |
1.092e-09 |
163 |
NEGATIVE REGULATION OF PROTEIN BINDING |
10 |
79 |
3.864e-11 |
1.103e-09 |
164 |
RESPONSE TO RETINOIC ACID |
11 |
107 |
3.963e-11 |
1.124e-09 |
165 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
56 |
4.12e-11 |
1.155e-09 |
166 |
REGULATION OF MITOTIC CELL CYCLE |
19 |
468 |
4.097e-11 |
1.155e-09 |
167 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
17 |
360 |
4.618e-11 |
1.287e-09 |
168 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
14 |
218 |
4.743e-11 |
1.306e-09 |
169 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
19 |
472 |
4.739e-11 |
1.306e-09 |
170 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
15 |
263 |
4.988e-11 |
1.358e-09 |
171 |
REGULATION OF CATABOLIC PROCESS |
23 |
731 |
4.989e-11 |
1.358e-09 |
172 |
RESPONSE TO GROWTH FACTOR |
19 |
475 |
5.28e-11 |
1.428e-09 |
173 |
FORMATION OF PRIMARY GERM LAYER |
11 |
110 |
5.372e-11 |
1.445e-09 |
174 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
11 |
112 |
6.547e-11 |
1.751e-09 |
175 |
RESPONSE TO LIPID |
25 |
888 |
6.791e-11 |
1.806e-09 |
176 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
17 |
370 |
7.081e-11 |
1.872e-09 |
177 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
21 |
609 |
7.247e-11 |
1.905e-09 |
178 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
15 |
271 |
7.609e-11 |
1.989e-09 |
179 |
MUSCLE STRUCTURE DEVELOPMENT |
18 |
432 |
9.207e-11 |
2.393e-09 |
180 |
STEM CELL DIFFERENTIATION |
13 |
190 |
1.102e-10 |
2.849e-09 |
181 |
MITOTIC CELL CYCLE |
23 |
766 |
1.259e-10 |
3.237e-09 |
182 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
15 |
282 |
1.33e-10 |
3.4e-09 |
183 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
11 |
121 |
1.523e-10 |
3.873e-09 |
184 |
INNER EAR MORPHOGENESIS |
10 |
92 |
1.813e-10 |
4.584e-09 |
185 |
MESODERM MORPHOGENESIS |
9 |
66 |
1.916e-10 |
4.792e-09 |
186 |
REGULATION OF PROTEOLYSIS |
22 |
711 |
1.913e-10 |
4.792e-09 |
187 |
GLAND DEVELOPMENT |
17 |
395 |
1.95e-10 |
4.853e-09 |
188 |
REGULATION OF IMMUNE RESPONSE |
24 |
858 |
1.985e-10 |
4.914e-09 |
189 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
19 |
514 |
2.013e-10 |
4.956e-09 |
190 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
67 |
2.202e-10 |
5.392e-09 |
191 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
17 |
404 |
2.759e-10 |
6.687e-09 |
192 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
24 |
872 |
2.754e-10 |
6.687e-09 |
193 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
24 |
876 |
3.021e-10 |
7.283e-09 |
194 |
POSITIVE REGULATION OF CELL PROLIFERATION |
23 |
814 |
4.136e-10 |
9.921e-09 |
195 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
12 |
171 |
4.449e-10 |
1.062e-08 |
196 |
POSITIVE REGULATION OF PROTEOLYSIS |
16 |
363 |
4.923e-10 |
1.163e-08 |
197 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
16 |
363 |
4.923e-10 |
1.163e-08 |
198 |
POSITIVE REGULATION OF KINASE ACTIVITY |
18 |
482 |
5.381e-10 |
1.261e-08 |
199 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
8 |
50 |
5.395e-10 |
1.261e-08 |
200 |
IMMUNE SYSTEM PROCESS |
36 |
1984 |
5.491e-10 |
1.277e-08 |
201 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
10 |
103 |
5.615e-10 |
1.3e-08 |
202 |
REGULATION OF OSSIFICATION |
12 |
178 |
7.065e-10 |
1.627e-08 |
203 |
REGULATION OF MAP KINASE ACTIVITY |
15 |
319 |
7.364e-10 |
1.688e-08 |
204 |
REGULATION OF FAT CELL DIFFERENTIATION |
10 |
106 |
7.47e-10 |
1.704e-08 |
205 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
22 |
767 |
7.948e-10 |
1.804e-08 |
206 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
8 |
53 |
8.776e-10 |
1.973e-08 |
207 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
22 |
771 |
8.756e-10 |
1.973e-08 |
208 |
REGULATION OF CELL ADHESION |
20 |
629 |
8.895e-10 |
1.99e-08 |
209 |
REGULATION OF GROWTH |
20 |
633 |
9.924e-10 |
2.204e-08 |
210 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
11 |
144 |
9.949e-10 |
2.204e-08 |
211 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
34 |
1.04e-09 |
2.294e-08 |
212 |
EAR MORPHOGENESIS |
10 |
112 |
1.288e-09 |
2.827e-08 |
213 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
20 |
643 |
1.3e-09 |
2.839e-08 |
214 |
PEPTIDYL SERINE MODIFICATION |
11 |
148 |
1.333e-09 |
2.871e-08 |
215 |
DIGESTIVE SYSTEM DEVELOPMENT |
11 |
148 |
1.333e-09 |
2.871e-08 |
216 |
RESPONSE TO ABIOTIC STIMULUS |
25 |
1024 |
1.32e-09 |
2.871e-08 |
217 |
OUTFLOW TRACT MORPHOGENESIS |
8 |
56 |
1.386e-09 |
2.971e-08 |
218 |
REGULATION OF CELL GROWTH |
16 |
391 |
1.444e-09 |
3.081e-08 |
219 |
NEGATIVE REGULATION OF CELL DEATH |
23 |
872 |
1.56e-09 |
3.315e-08 |
220 |
SINGLE ORGANISM CELL ADHESION |
17 |
459 |
1.924e-09 |
4.051e-08 |
221 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
14 |
289 |
1.923e-09 |
4.051e-08 |
222 |
MAMMARY GLAND DEVELOPMENT |
10 |
117 |
1.98e-09 |
4.151e-08 |
223 |
MESODERM DEVELOPMENT |
10 |
118 |
2.153e-09 |
4.492e-08 |
224 |
STEM CELL PROLIFERATION |
8 |
60 |
2.447e-09 |
5.061e-08 |
225 |
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY |
8 |
60 |
2.447e-09 |
5.061e-08 |
226 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
16 |
406 |
2.478e-09 |
5.101e-08 |
227 |
VASCULATURE DEVELOPMENT |
17 |
469 |
2.66e-09 |
5.452e-08 |
228 |
POSITIVE REGULATION OF MAPK CASCADE |
17 |
470 |
2.746e-09 |
5.604e-08 |
229 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
19 |
602 |
2.78e-09 |
5.648e-08 |
230 |
CELLULAR COMPONENT MORPHOGENESIS |
23 |
900 |
2.85e-09 |
5.766e-08 |
231 |
COCHLEA DEVELOPMENT |
7 |
39 |
2.902e-09 |
5.846e-08 |
232 |
UROGENITAL SYSTEM DEVELOPMENT |
14 |
299 |
2.979e-09 |
5.975e-08 |
233 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
20 |
684 |
3.737e-09 |
7.462e-08 |
234 |
CELL CYCLE PHASE TRANSITION |
13 |
255 |
4.081e-09 |
8.116e-08 |
235 |
REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY |
6 |
24 |
4.818e-09 |
9.541e-08 |
236 |
NEGATIVE REGULATION OF CELL GROWTH |
11 |
170 |
5.77e-09 |
1.138e-07 |
237 |
RESPONSE TO DRUG |
16 |
431 |
5.801e-09 |
1.139e-07 |
238 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
13 |
263 |
5.918e-09 |
1.157e-07 |
239 |
POSITIVE REGULATION OF TRANSPORT |
23 |
936 |
5.98e-09 |
1.164e-07 |
240 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
13 |
264 |
6.193e-09 |
1.201e-07 |
241 |
CELLULAR RESPONSE TO STRESS |
30 |
1565 |
6.552e-09 |
1.265e-07 |
242 |
REGULATION OF CELL JUNCTION ASSEMBLY |
8 |
68 |
6.796e-09 |
1.307e-07 |
243 |
REGULATION OF CELL SUBSTRATE ADHESION |
11 |
173 |
6.931e-09 |
1.327e-07 |
244 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
14 |
321 |
7.376e-09 |
1.407e-07 |
245 |
MESENCHYMAL CELL DIFFERENTIATION |
10 |
134 |
7.44e-09 |
1.413e-07 |
246 |
CELLULAR RESPONSE TO ACID CHEMICAL |
11 |
175 |
7.817e-09 |
1.478e-07 |
247 |
REGULATION OF CELL FATE SPECIFICATION |
5 |
13 |
8.489e-09 |
1.599e-07 |
248 |
EYE DEVELOPMENT |
14 |
326 |
8.974e-09 |
1.684e-07 |
249 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
13 |
274 |
9.663e-09 |
1.806e-07 |
250 |
PEPTIDYL THREONINE MODIFICATION |
7 |
46 |
9.758e-09 |
1.816e-07 |
251 |
PROTEIN COMPLEX BIOGENESIS |
25 |
1132 |
9.994e-09 |
1.845e-07 |
252 |
PROTEIN COMPLEX ASSEMBLY |
25 |
1132 |
9.994e-09 |
1.845e-07 |
253 |
IMMUNE SYSTEM DEVELOPMENT |
18 |
582 |
1.04e-08 |
1.906e-07 |
254 |
DEVELOPMENTAL INDUCTION |
6 |
27 |
1.044e-08 |
1.906e-07 |
255 |
AXIS ELONGATION |
6 |
27 |
1.044e-08 |
1.906e-07 |
256 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
12 |
229 |
1.228e-08 |
2.233e-07 |
257 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
15 |
395 |
1.333e-08 |
2.413e-07 |
258 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
9 |
106 |
1.394e-08 |
2.513e-07 |
259 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
13 |
285 |
1.544e-08 |
2.773e-07 |
260 |
NEGATIVE REGULATION OF GROWTH |
12 |
236 |
1.718e-08 |
3.075e-07 |
261 |
REGULATION OF MESODERM DEVELOPMENT |
5 |
15 |
1.962e-08 |
3.498e-07 |
262 |
RESPONSE TO ENDOGENOUS STIMULUS |
28 |
1450 |
2.029e-08 |
3.603e-07 |
263 |
RESPIRATORY SYSTEM DEVELOPMENT |
11 |
197 |
2.673e-08 |
4.73e-07 |
264 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
10 |
154 |
2.834e-08 |
4.96e-07 |
265 |
FOREBRAIN DEVELOPMENT |
14 |
357 |
2.815e-08 |
4.96e-07 |
266 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
12 |
247 |
2.846e-08 |
4.96e-07 |
267 |
PARAXIAL MESODERM DEVELOPMENT |
5 |
16 |
2.84e-08 |
4.96e-07 |
268 |
KIDNEY MORPHOGENESIS |
8 |
82 |
3.058e-08 |
5.309e-07 |
269 |
REGULATION OF ORGAN FORMATION |
6 |
32 |
3.121e-08 |
5.398e-07 |
270 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
117 |
3.319e-08 |
5.719e-07 |
271 |
REPRODUCTION |
26 |
1297 |
3.446e-08 |
5.917e-07 |
272 |
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT |
6 |
33 |
3.796e-08 |
6.493e-07 |
273 |
REGULATION OF CHROMATIN BINDING |
5 |
17 |
4.005e-08 |
6.826e-07 |
274 |
LEUKOCYTE CELL CELL ADHESION |
12 |
255 |
4.045e-08 |
6.869e-07 |
275 |
PALATE DEVELOPMENT |
8 |
85 |
4.068e-08 |
6.883e-07 |
276 |
IN UTERO EMBRYONIC DEVELOPMENT |
13 |
311 |
4.322e-08 |
7.286e-07 |
277 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
11 |
207 |
4.447e-08 |
7.47e-07 |
278 |
NEGATIVE REGULATION OF CELL CYCLE |
15 |
433 |
4.486e-08 |
7.509e-07 |
279 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
6 |
34 |
4.587e-08 |
7.622e-07 |
280 |
BRAIN MORPHOGENESIS |
6 |
34 |
4.587e-08 |
7.622e-07 |
281 |
EMBRYONIC PATTERN SPECIFICATION |
7 |
58 |
5.168e-08 |
8.558e-07 |
282 |
REGULATION OF STEM CELL PROLIFERATION |
8 |
88 |
5.353e-08 |
8.833e-07 |
283 |
POST ANAL TAIL MORPHOGENESIS |
5 |
18 |
5.519e-08 |
9.042e-07 |
284 |
INOSITOL PHOSPHATE MEDIATED SIGNALING |
5 |
18 |
5.519e-08 |
9.042e-07 |
285 |
RESPONSE TO ACID CHEMICAL |
13 |
319 |
5.816e-08 |
9.495e-07 |
286 |
KIDNEY EPITHELIUM DEVELOPMENT |
9 |
125 |
5.905e-08 |
9.607e-07 |
287 |
MESONEPHROS DEVELOPMENT |
8 |
90 |
6.392e-08 |
1.036e-06 |
288 |
APPENDAGE DEVELOPMENT |
10 |
169 |
6.845e-08 |
1.102e-06 |
289 |
LIMB DEVELOPMENT |
10 |
169 |
6.845e-08 |
1.102e-06 |
290 |
REGULATION OF PHOSPHATASE ACTIVITY |
9 |
128 |
7.253e-08 |
1.164e-06 |
291 |
EMBRYONIC DIGIT MORPHOGENESIS |
7 |
61 |
7.39e-08 |
1.182e-06 |
292 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
5 |
19 |
7.454e-08 |
1.188e-06 |
293 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
21 |
905 |
7.998e-08 |
1.27e-06 |
294 |
MESENCHYME MORPHOGENESIS |
6 |
38 |
9.234e-08 |
1.461e-06 |
295 |
REGULATION OF MUSCLE ADAPTATION |
7 |
63 |
9.28e-08 |
1.464e-06 |
296 |
DEVELOPMENTAL GROWTH |
13 |
333 |
9.583e-08 |
1.506e-06 |
297 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
22 |
1008 |
1.095e-07 |
1.715e-06 |
298 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
15 |
465 |
1.135e-07 |
1.772e-06 |
299 |
EYE MORPHOGENESIS |
9 |
136 |
1.224e-07 |
1.905e-06 |
300 |
REGULATION OF MEIOTIC CELL CYCLE |
6 |
40 |
1.272e-07 |
1.966e-06 |
301 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
6 |
40 |
1.272e-07 |
1.966e-06 |
302 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
7 |
66 |
1.287e-07 |
1.983e-06 |
303 |
POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
5 |
21 |
1.292e-07 |
1.984e-06 |
304 |
LYMPHOCYTE ACTIVATION |
13 |
342 |
1.304e-07 |
1.99e-06 |
305 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
10 |
181 |
1.304e-07 |
1.99e-06 |
306 |
CELL CELL SIGNALING |
19 |
767 |
1.32e-07 |
2.007e-06 |
307 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
16 |
541 |
1.358e-07 |
2.051e-06 |
308 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
16 |
541 |
1.358e-07 |
2.051e-06 |
309 |
LOCOMOTION |
23 |
1114 |
1.458e-07 |
2.196e-06 |
310 |
MACROMOLECULAR COMPLEX ASSEMBLY |
26 |
1398 |
1.527e-07 |
2.292e-06 |
311 |
BIOLOGICAL ADHESION |
22 |
1032 |
1.645e-07 |
2.461e-06 |
312 |
LEUKOCYTE ACTIVATION |
14 |
414 |
1.75e-07 |
2.61e-06 |
313 |
MUSCLE CELL DIFFERENTIATION |
11 |
237 |
1.758e-07 |
2.613e-06 |
314 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
8 |
103 |
1.839e-07 |
2.699e-06 |
315 |
REGULATION OF CIRCADIAN RHYTHM |
8 |
103 |
1.839e-07 |
2.699e-06 |
316 |
POSITIVE REGULATION OF GROWTH |
11 |
238 |
1.834e-07 |
2.699e-06 |
317 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
8 |
103 |
1.839e-07 |
2.699e-06 |
318 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
20 |
867 |
1.869e-07 |
2.735e-06 |
319 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
8 |
104 |
1.982e-07 |
2.891e-06 |
320 |
SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
5 |
23 |
2.116e-07 |
3.077e-06 |
321 |
RESPONSE TO CYTOKINE |
18 |
714 |
2.268e-07 |
3.287e-06 |
322 |
FAT CELL DIFFERENTIATION |
8 |
106 |
2.298e-07 |
3.321e-06 |
323 |
EPITHELIAL CELL DIFFERENTIATION |
15 |
495 |
2.535e-07 |
3.652e-06 |
324 |
EAR DEVELOPMENT |
10 |
195 |
2.61e-07 |
3.749e-06 |
325 |
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY |
5 |
24 |
2.661e-07 |
3.807e-06 |
326 |
BLOOD VESSEL MORPHOGENESIS |
13 |
364 |
2.667e-07 |
3.807e-06 |
327 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
18 |
724 |
2.782e-07 |
3.959e-06 |
328 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
10 |
199 |
3.15e-07 |
4.469e-06 |
329 |
REGULATION OF CELLULAR RESPONSE TO HEAT |
7 |
76 |
3.44e-07 |
4.866e-06 |
330 |
REGULATION OF BMP SIGNALING PATHWAY |
7 |
77 |
3.766e-07 |
5.31e-06 |
331 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
4 |
11 |
3.807e-07 |
5.352e-06 |
332 |
POSITIVE REGULATION OF CELL ADHESION |
13 |
376 |
3.858e-07 |
5.406e-06 |
333 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
6 |
48 |
3.911e-07 |
5.464e-06 |
334 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
22 |
1087 |
3.996e-07 |
5.567e-06 |
335 |
REGULATION OF CELL FATE COMMITMENT |
5 |
26 |
4.079e-07 |
5.665e-06 |
336 |
REGULATION OF DEPHOSPHORYLATION |
9 |
158 |
4.396e-07 |
6.088e-06 |
337 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
20 |
917 |
4.55e-07 |
6.282e-06 |
338 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
5 |
27 |
4.982e-07 |
6.859e-06 |
339 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
6 |
50 |
5.015e-07 |
6.884e-06 |
340 |
REGULATION OF FIBROBLAST PROLIFERATION |
7 |
81 |
5.34e-07 |
7.308e-06 |
341 |
SKELETAL SYSTEM DEVELOPMENT |
14 |
455 |
5.466e-07 |
7.458e-06 |
342 |
SEX DIFFERENTIATION |
11 |
266 |
5.56e-07 |
7.564e-06 |
343 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
6 |
51 |
5.656e-07 |
7.673e-06 |
344 |
GASTRULATION WITH MOUTH FORMING SECOND |
5 |
28 |
6.036e-07 |
8.165e-06 |
345 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
8 |
121 |
6.367e-07 |
8.587e-06 |
346 |
CELL CELL ADHESION |
16 |
608 |
6.475e-07 |
8.707e-06 |
347 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
9 |
166 |
6.666e-07 |
8.939e-06 |
348 |
POSITIVE REGULATION OF OSSIFICATION |
7 |
84 |
6.854e-07 |
9.164e-06 |
349 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
9 |
167 |
7.011e-07 |
9.347e-06 |
350 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
16 |
616 |
7.692e-07 |
1.023e-05 |
351 |
WOUND HEALING |
14 |
470 |
8.042e-07 |
1.066e-05 |
352 |
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY |
4 |
13 |
8.173e-07 |
1.08e-05 |
353 |
REGULATION OF PROTEIN STABILITY |
10 |
221 |
8.248e-07 |
1.087e-05 |
354 |
REGULATION OF CHROMOSOME ORGANIZATION |
11 |
278 |
8.588e-07 |
1.129e-05 |
355 |
RESPONSE TO UV |
8 |
126 |
8.671e-07 |
1.136e-05 |
356 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION |
8 |
128 |
9.773e-07 |
1.277e-05 |
357 |
GROWTH |
13 |
410 |
1.022e-06 |
1.332e-05 |
358 |
REGULATION OF REPRODUCTIVE PROCESS |
8 |
129 |
1.037e-06 |
1.348e-05 |
359 |
CALCIUM MEDIATED SIGNALING |
7 |
90 |
1.098e-06 |
1.419e-05 |
360 |
REGULATION OF CELL MATRIX ADHESION |
7 |
90 |
1.098e-06 |
1.419e-05 |
361 |
PATTERNING OF BLOOD VESSELS |
5 |
32 |
1.214e-06 |
1.564e-05 |
362 |
REGULATION OF DEVELOPMENTAL GROWTH |
11 |
289 |
1.256e-06 |
1.609e-05 |
363 |
APOPTOTIC SIGNALING PATHWAY |
11 |
289 |
1.256e-06 |
1.609e-05 |
364 |
RESPONSE TO WOUNDING |
15 |
563 |
1.281e-06 |
1.638e-05 |
365 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
13 |
422 |
1.408e-06 |
1.795e-05 |
366 |
EMBRYONIC AXIS SPECIFICATION |
5 |
33 |
1.424e-06 |
1.81e-05 |
367 |
ANGIOGENESIS |
11 |
293 |
1.436e-06 |
1.82e-05 |
368 |
CELLULAR RESPONSE TO RADIATION |
8 |
137 |
1.634e-06 |
2.066e-05 |
369 |
PROTEIN DESTABILIZATION |
5 |
34 |
1.661e-06 |
2.089e-05 |
370 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
6 |
61 |
1.662e-06 |
2.089e-05 |
371 |
RESPONSE TO ALCOHOL |
12 |
362 |
1.721e-06 |
2.159e-05 |
372 |
CELL CYCLE G2 M PHASE TRANSITION |
8 |
138 |
1.726e-06 |
2.159e-05 |
373 |
REGULATION OF CYTOSKELETON ORGANIZATION |
14 |
502 |
1.747e-06 |
2.179e-05 |
374 |
PROTEIN CATABOLIC PROCESS |
15 |
579 |
1.811e-06 |
2.253e-05 |
375 |
REGULATION OF GASTRULATION |
5 |
35 |
1.929e-06 |
2.393e-05 |
376 |
REGULATION OF EPIDERMIS DEVELOPMENT |
6 |
63 |
2.014e-06 |
2.492e-05 |
377 |
PROTEIN DEPHOSPHORYLATION |
9 |
190 |
2.053e-06 |
2.52e-05 |
378 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
4 |
16 |
2.052e-06 |
2.52e-05 |
379 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
4 |
16 |
2.052e-06 |
2.52e-05 |
380 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
7 |
99 |
2.093e-06 |
2.563e-05 |
381 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
10 |
246 |
2.173e-06 |
2.654e-05 |
382 |
RESPONSE TO EXTERNAL STIMULUS |
28 |
1821 |
2.19e-06 |
2.667e-05 |
383 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
9 |
192 |
2.238e-06 |
2.7e-05 |
384 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
7 |
100 |
2.24e-06 |
2.7e-05 |
385 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
36 |
2.229e-06 |
2.7e-05 |
386 |
PROTEIN AUTOPHOSPHORYLATION |
9 |
192 |
2.238e-06 |
2.7e-05 |
387 |
CARDIAC CHAMBER DEVELOPMENT |
8 |
144 |
2.377e-06 |
2.857e-05 |
388 |
PEPTIDYL AMINO ACID MODIFICATION |
18 |
841 |
2.391e-06 |
2.864e-05 |
389 |
CAMERA TYPE EYE MORPHOGENESIS |
7 |
101 |
2.395e-06 |
2.864e-05 |
390 |
CONNECTIVE TISSUE DEVELOPMENT |
9 |
194 |
2.437e-06 |
2.908e-05 |
391 |
RESPONSE TO OXYGEN LEVELS |
11 |
311 |
2.557e-06 |
3.037e-05 |
392 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
7 |
102 |
2.559e-06 |
3.037e-05 |
393 |
CELLULAR RESPONSE TO UV |
6 |
66 |
2.654e-06 |
3.134e-05 |
394 |
FOREBRAIN GENERATION OF NEURONS |
6 |
66 |
2.654e-06 |
3.134e-05 |
395 |
ESTABLISHMENT OF TISSUE POLARITY |
4 |
17 |
2.671e-06 |
3.138e-05 |
396 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
2.671e-06 |
3.138e-05 |
397 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
8 |
148 |
2.917e-06 |
3.385e-05 |
398 |
CARDIAC CHAMBER MORPHOGENESIS |
7 |
104 |
2.915e-06 |
3.385e-05 |
399 |
POSITIVE REGULATION OF CELL GROWTH |
8 |
148 |
2.917e-06 |
3.385e-05 |
400 |
POSITIVE REGULATION OF PROTEIN IMPORT |
7 |
104 |
2.915e-06 |
3.385e-05 |
401 |
MALE SEX DIFFERENTIATION |
8 |
148 |
2.917e-06 |
3.385e-05 |
402 |
REGULATION OF CELL MATURATION |
4 |
18 |
3.418e-06 |
3.947e-05 |
403 |
PERICARDIUM DEVELOPMENT |
4 |
18 |
3.418e-06 |
3.947e-05 |
404 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
152 |
3.558e-06 |
4.098e-05 |
405 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
9 |
204 |
3.68e-06 |
4.228e-05 |
406 |
NEURAL PRECURSOR CELL PROLIFERATION |
6 |
70 |
3.756e-06 |
4.284e-05 |
407 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
7 |
108 |
3.751e-06 |
4.284e-05 |
408 |
REGULATION OF MEMBRANE PERMEABILITY |
6 |
70 |
3.756e-06 |
4.284e-05 |
409 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
262 |
3.812e-06 |
4.337e-05 |
410 |
NEURON PROJECTION GUIDANCE |
9 |
205 |
3.83e-06 |
4.347e-05 |
411 |
SKIN EPIDERMIS DEVELOPMENT |
6 |
71 |
4.083e-06 |
4.611e-05 |
412 |
ENDODERM DEVELOPMENT |
6 |
71 |
4.083e-06 |
4.611e-05 |
413 |
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
4 |
19 |
4.31e-06 |
4.856e-05 |
414 |
LYMPHOCYTE DIFFERENTIATION |
9 |
209 |
4.484e-06 |
5.039e-05 |
415 |
NEURON PROJECTION DEVELOPMENT |
14 |
545 |
4.524e-06 |
5.073e-05 |
416 |
EMBRYONIC HEART TUBE DEVELOPMENT |
6 |
73 |
4.807e-06 |
5.376e-05 |
417 |
SKIN DEVELOPMENT |
9 |
211 |
4.845e-06 |
5.406e-05 |
418 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
5 |
42 |
4.889e-06 |
5.442e-05 |
419 |
RESPONSE TO METAL ION |
11 |
333 |
4.92e-06 |
5.464e-05 |
420 |
SECOND MESSENGER MEDIATED SIGNALING |
8 |
160 |
5.205e-06 |
5.767e-05 |
421 |
REGULATION OF CELL DIVISION |
10 |
272 |
5.31e-06 |
5.868e-05 |
422 |
TRACHEA DEVELOPMENT |
4 |
20 |
5.363e-06 |
5.885e-05 |
423 |
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
20 |
5.363e-06 |
5.885e-05 |
424 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
5.363e-06 |
5.885e-05 |
425 |
REGULATION OF NEURON DIFFERENTIATION |
14 |
554 |
5.457e-06 |
5.974e-05 |
426 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
5 |
43 |
5.506e-06 |
5.986e-05 |
427 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
5 |
43 |
5.506e-06 |
5.986e-05 |
428 |
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
43 |
5.506e-06 |
5.986e-05 |
429 |
RESPONSE TO INORGANIC SUBSTANCE |
13 |
479 |
5.631e-06 |
6.107e-05 |
430 |
NEPHRON DEVELOPMENT |
7 |
115 |
5.696e-06 |
6.164e-05 |
431 |
LABYRINTHINE LAYER DEVELOPMENT |
5 |
44 |
6.182e-06 |
6.659e-05 |
432 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
5 |
44 |
6.182e-06 |
6.659e-05 |
433 |
REGULATION OF MITOCHONDRION ORGANIZATION |
9 |
218 |
6.313e-06 |
6.784e-05 |
434 |
SPECIFICATION OF SYMMETRY |
7 |
117 |
6.385e-06 |
6.846e-05 |
435 |
REGULATION OF CYTOKINE PRODUCTION |
14 |
563 |
6.556e-06 |
6.992e-05 |
436 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
6 |
77 |
6.566e-06 |
6.992e-05 |
437 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
14 |
563 |
6.556e-06 |
6.992e-05 |
438 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
4 |
21 |
6.594e-06 |
7.005e-05 |
439 |
RESPONSE TO RADIATION |
12 |
413 |
6.646e-06 |
7.044e-05 |
440 |
THYMOCYTE AGGREGATION |
5 |
45 |
6.922e-06 |
7.304e-05 |
441 |
T CELL DIFFERENTIATION IN THYMUS |
5 |
45 |
6.922e-06 |
7.304e-05 |
442 |
RENAL TUBULE DEVELOPMENT |
6 |
78 |
7.079e-06 |
7.452e-05 |
443 |
SOMATIC STEM CELL DIVISION |
4 |
22 |
8.022e-06 |
8.426e-05 |
444 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
17 |
829 |
8.248e-06 |
8.644e-05 |
445 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
122 |
8.415e-06 |
8.799e-05 |
446 |
T CELL DIFFERENTIATION |
7 |
123 |
8.88e-06 |
9.264e-05 |
447 |
ACTIVATION OF IMMUNE RESPONSE |
12 |
427 |
9.297e-06 |
9.678e-05 |
448 |
JNK CASCADE |
6 |
82 |
9.466e-06 |
9.832e-05 |
449 |
LEUKOCYTE DIFFERENTIATION |
10 |
292 |
9.888e-06 |
0.0001025 |
450 |
HAIR CYCLE |
6 |
83 |
1.015e-05 |
0.0001048 |
451 |
MOLTING CYCLE |
6 |
83 |
1.015e-05 |
0.0001048 |
452 |
OSTEOBLAST DIFFERENTIATION |
7 |
126 |
1.04e-05 |
0.0001068 |
453 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
126 |
1.04e-05 |
0.0001068 |
454 |
CARDIAC SEPTUM MORPHOGENESIS |
5 |
49 |
1.06e-05 |
0.0001086 |
455 |
REGULATION OF VASCULATURE DEVELOPMENT |
9 |
233 |
1.078e-05 |
0.0001103 |
456 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
6 |
84 |
1.088e-05 |
0.000111 |
457 |
REGULATION OF GTPASE ACTIVITY |
15 |
673 |
1.113e-05 |
0.0001134 |
458 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
7 |
128 |
1.153e-05 |
0.0001172 |
459 |
CARDIAC SEPTUM DEVELOPMENT |
6 |
85 |
1.165e-05 |
0.0001181 |
460 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
7 |
129 |
1.213e-05 |
0.0001227 |
461 |
RESPONSE TO NITROGEN COMPOUND |
17 |
859 |
1.309e-05 |
0.0001321 |
462 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
11 |
370 |
1.326e-05 |
0.0001336 |
463 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
10 |
303 |
1.363e-05 |
0.000137 |
464 |
MAINTENANCE OF CELL NUMBER |
7 |
132 |
1.41e-05 |
0.0001414 |
465 |
NEURON DEVELOPMENT |
15 |
687 |
1.419e-05 |
0.000142 |
466 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
5 |
53 |
1.565e-05 |
0.0001557 |
467 |
EPITHELIAL CELL DEVELOPMENT |
8 |
186 |
1.566e-05 |
0.0001557 |
468 |
MESONEPHRIC TUBULE MORPHOGENESIS |
5 |
53 |
1.565e-05 |
0.0001557 |
469 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
4 |
26 |
1.61e-05 |
0.0001597 |
470 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
8 |
188 |
1.692e-05 |
0.0001675 |
471 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
6 |
91 |
1.725e-05 |
0.0001704 |
472 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
10 |
312 |
1.754e-05 |
0.0001729 |
473 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
6 |
92 |
1.837e-05 |
0.0001807 |
474 |
NEGATIVE REGULATION OF TRANSPORT |
12 |
458 |
1.867e-05 |
0.0001833 |
475 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
9 |
250 |
1.889e-05 |
0.0001835 |
476 |
REGULATION OF KIDNEY DEVELOPMENT |
5 |
55 |
1.88e-05 |
0.0001835 |
477 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
21 |
1275 |
1.885e-05 |
0.0001835 |
478 |
RESPONSE TO LITHIUM ION |
4 |
27 |
1.881e-05 |
0.0001835 |
479 |
PLACENTA DEVELOPMENT |
7 |
138 |
1.882e-05 |
0.0001835 |
480 |
NEPHRON EPITHELIUM DEVELOPMENT |
6 |
93 |
1.954e-05 |
0.000189 |
481 |
REGULATION OF DNA BINDING |
6 |
93 |
1.954e-05 |
0.000189 |
482 |
MITOTIC CELL CYCLE CHECKPOINT |
7 |
139 |
1.972e-05 |
0.0001904 |
483 |
TAXIS |
12 |
464 |
2.123e-05 |
0.0002045 |
484 |
RESPONSE TO HORMONE |
17 |
893 |
2.153e-05 |
0.000207 |
485 |
VENTRICULAR SEPTUM MORPHOGENESIS |
4 |
28 |
2.184e-05 |
0.0002087 |
486 |
MORPHOGENESIS OF A POLARIZED EPITHELIUM |
4 |
28 |
2.184e-05 |
0.0002087 |
487 |
MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
28 |
2.184e-05 |
0.0002087 |
488 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
6 |
95 |
2.206e-05 |
0.00021 |
489 |
REGULATION OF MUSCLE SYSTEM PROCESS |
8 |
195 |
2.202e-05 |
0.00021 |
490 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
8 |
197 |
2.37e-05 |
0.000225 |
491 |
CELL PROJECTION ORGANIZATION |
17 |
902 |
2.445e-05 |
0.0002317 |
492 |
REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
4 |
29 |
2.522e-05 |
0.0002371 |
493 |
POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
4 |
29 |
2.522e-05 |
0.0002371 |
494 |
STEM CELL DIVISION |
4 |
29 |
2.522e-05 |
0.0002371 |
495 |
REGULATION OF HEART MORPHOGENESIS |
4 |
29 |
2.522e-05 |
0.0002371 |
496 |
SYNAPSE ORGANIZATION |
7 |
145 |
2.591e-05 |
0.0002431 |
497 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
7 |
146 |
2.709e-05 |
0.0002536 |
498 |
SKELETAL SYSTEM MORPHOGENESIS |
8 |
201 |
2.737e-05 |
0.0002557 |
499 |
NEGATIVE REGULATION OF LOCOMOTION |
9 |
263 |
2.815e-05 |
0.0002625 |
500 |
CARTILAGE DEVELOPMENT |
7 |
147 |
2.83e-05 |
0.0002629 |
501 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
7 |
147 |
2.83e-05 |
0.0002629 |
502 |
PROTEOLYSIS |
20 |
1208 |
2.848e-05 |
0.000264 |
503 |
CHROMOSOME ORGANIZATION |
18 |
1009 |
2.855e-05 |
0.0002641 |
504 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
60 |
2.882e-05 |
0.0002661 |
505 |
RESPONSE TO X RAY |
4 |
30 |
2.897e-05 |
0.0002669 |
506 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
4 |
31 |
3.311e-05 |
0.0003045 |
507 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
8 |
207 |
3.376e-05 |
0.0003092 |
508 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
5 |
62 |
3.382e-05 |
0.0003092 |
509 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
5 |
62 |
3.382e-05 |
0.0003092 |
510 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
8 |
209 |
3.615e-05 |
0.0003298 |
511 |
PALLIUM DEVELOPMENT |
7 |
153 |
3.658e-05 |
0.0003331 |
512 |
RESPONSE TO MECHANICAL STIMULUS |
8 |
210 |
3.74e-05 |
0.0003399 |
513 |
CHROMATIN ORGANIZATION |
14 |
663 |
4.031e-05 |
0.0003656 |
514 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
7 |
156 |
4.141e-05 |
0.0003741 |
515 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
8 |
213 |
4.136e-05 |
0.0003741 |
516 |
POSITIVE REGULATION OF LOCOMOTION |
11 |
420 |
4.246e-05 |
0.0003829 |
517 |
REGULATION OF PROTEIN EXPORT FROM NUCLEUS |
4 |
33 |
4.266e-05 |
0.000384 |
518 |
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION |
3 |
12 |
4.345e-05 |
0.0003873 |
519 |
TRACHEA MORPHOGENESIS |
3 |
12 |
4.345e-05 |
0.0003873 |
520 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
12 |
4.345e-05 |
0.0003873 |
521 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
12 |
4.345e-05 |
0.0003873 |
522 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
3 |
12 |
4.345e-05 |
0.0003873 |
523 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
8 |
216 |
4.566e-05 |
0.0004062 |
524 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
5 |
66 |
4.584e-05 |
0.0004065 |
525 |
RESPONSE TO LIGHT STIMULUS |
9 |
280 |
4.587e-05 |
0.0004065 |
526 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
10 |
351 |
4.77e-05 |
0.000422 |
527 |
REGULATION OF PROTEIN DEACETYLATION |
4 |
34 |
4.813e-05 |
0.000425 |
528 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
5 |
67 |
4.93e-05 |
0.0004336 |
529 |
REGULATION OF SISTER CHROMATID SEGREGATION |
5 |
67 |
4.93e-05 |
0.0004336 |
530 |
PROTEIN LOCALIZATION |
25 |
1805 |
5.069e-05 |
0.000445 |
531 |
CELL CYCLE G1 S PHASE TRANSITION |
6 |
111 |
5.321e-05 |
0.0004654 |
532 |
G1 S TRANSITION OF MITOTIC CELL CYCLE |
6 |
111 |
5.321e-05 |
0.0004654 |
533 |
BONE REMODELING |
4 |
35 |
5.409e-05 |
0.0004713 |
534 |
DEPHOSPHORYLATION |
9 |
286 |
5.403e-05 |
0.0004713 |
535 |
REGULATION OF NUCLEAR DIVISION |
7 |
163 |
5.473e-05 |
0.0004751 |
536 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
7 |
163 |
5.473e-05 |
0.0004751 |
537 |
REGULATION OF INNATE IMMUNE RESPONSE |
10 |
357 |
5.498e-05 |
0.0004764 |
538 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
5.624e-05 |
0.0004855 |
539 |
REGULATION OF SKELETAL MUSCLE ADAPTATION |
3 |
13 |
5.624e-05 |
0.0004855 |
540 |
SYNAPSE ASSEMBLY |
5 |
69 |
5.683e-05 |
0.0004897 |
541 |
HEAD MORPHOGENESIS |
4 |
36 |
6.058e-05 |
0.000521 |
542 |
MUSCLE ORGAN MORPHOGENESIS |
5 |
70 |
6.091e-05 |
0.0005229 |
543 |
CELLULAR RESPONSE TO ALCOHOL |
6 |
115 |
6.486e-05 |
0.0005538 |
544 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
10 |
364 |
6.464e-05 |
0.0005538 |
545 |
RESPONSE TO CALCIUM ION |
6 |
115 |
6.486e-05 |
0.0005538 |
546 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
5 |
71 |
6.522e-05 |
0.0005558 |
547 |
RESPONSE TO EXTRACELLULAR STIMULUS |
11 |
441 |
6.584e-05 |
0.00056 |
548 |
RESPONSE TO CARBOHYDRATE |
7 |
168 |
6.625e-05 |
0.0005626 |
549 |
TELENCEPHALON DEVELOPMENT |
8 |
228 |
6.68e-05 |
0.0005662 |
550 |
REGULATION OF MUSCLE HYPERTROPHY |
4 |
37 |
6.761e-05 |
0.000572 |
551 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
10 |
368 |
7.078e-05 |
0.0005977 |
552 |
POSITIVE REGULATION OF MEIOTIC CELL CYCLE |
3 |
14 |
7.127e-05 |
0.0005986 |
553 |
CELL MIGRATION INVOLVED IN GASTRULATION |
3 |
14 |
7.127e-05 |
0.0005986 |
554 |
REGULATION OF MONOCYTE DIFFERENTIATION |
3 |
14 |
7.127e-05 |
0.0005986 |
555 |
POSITIVE REGULATION OF PROTEIN BINDING |
5 |
73 |
7.453e-05 |
0.0006237 |
556 |
PANCREAS DEVELOPMENT |
5 |
73 |
7.453e-05 |
0.0006237 |
557 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
6 |
118 |
7.487e-05 |
0.0006254 |
558 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
19 |
1193 |
7.783e-05 |
0.000649 |
559 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
10 |
375 |
8.273e-05 |
0.0006887 |
560 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
9 |
303 |
8.413e-05 |
0.000699 |
561 |
NEURAL CREST CELL DIFFERENTIATION |
5 |
75 |
8.483e-05 |
0.0007036 |
562 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
3 |
15 |
8.87e-05 |
0.0007344 |
563 |
CHROMATIN MODIFICATION |
12 |
539 |
9e-05 |
0.0007439 |
564 |
MAMMARY GLAND MORPHOGENESIS |
4 |
40 |
9.227e-05 |
0.0007586 |
565 |
MITOCHONDRIAL TRANSPORT |
7 |
177 |
9.196e-05 |
0.0007586 |
566 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
4 |
40 |
9.227e-05 |
0.0007586 |
567 |
CELL DIVISION |
11 |
460 |
9.576e-05 |
0.0007859 |
568 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
0.0001018 |
0.0008338 |
569 |
ORGAN INDUCTION |
3 |
16 |
0.0001087 |
0.0008888 |
570 |
EPITHELIAL CELL MORPHOGENESIS |
4 |
42 |
0.000112 |
0.0009125 |
571 |
GENITALIA DEVELOPMENT |
4 |
42 |
0.000112 |
0.0009125 |
572 |
POSITIVE REGULATION OF BINDING |
6 |
127 |
0.0001125 |
0.0009149 |
573 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
7 |
183 |
0.0001132 |
0.0009195 |
574 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
5 |
80 |
0.0001154 |
0.0009355 |
575 |
MUSCLE CELL DEVELOPMENT |
6 |
128 |
0.0001174 |
0.0009503 |
576 |
MACROMOLECULE CATABOLIC PROCESS |
16 |
926 |
0.0001201 |
0.0009705 |
577 |
CELLULAR MACROMOLECULE LOCALIZATION |
19 |
1234 |
0.0001213 |
0.0009784 |
578 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
4 |
43 |
0.0001229 |
0.0009877 |
579 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
43 |
0.0001229 |
0.0009877 |
580 |
REGULATION OF CELL PROJECTION ORGANIZATION |
12 |
558 |
0.0001246 |
0.0009997 |
581 |
CELL MOTILITY |
15 |
835 |
0.0001304 |
0.00104 |
582 |
LOCALIZATION OF CELL |
15 |
835 |
0.0001304 |
0.00104 |
583 |
OSSIFICATION |
8 |
251 |
0.0001302 |
0.00104 |
584 |
REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
3 |
17 |
0.0001314 |
0.001045 |
585 |
CELLULAR RESPONSE TO LITHIUM ION |
3 |
17 |
0.0001314 |
0.001045 |
586 |
PROTEIN STABILIZATION |
6 |
131 |
0.0001334 |
0.001059 |
587 |
REGULATION OF HORMONE LEVELS |
11 |
478 |
0.0001342 |
0.001064 |
588 |
BODY MORPHOGENESIS |
4 |
44 |
0.0001346 |
0.001065 |
589 |
EMBRYONIC PLACENTA DEVELOPMENT |
5 |
83 |
0.0001374 |
0.001082 |
590 |
NIK NF KAPPAB SIGNALING |
5 |
83 |
0.0001374 |
0.001082 |
591 |
EPIDERMIS DEVELOPMENT |
8 |
253 |
0.0001375 |
0.001082 |
592 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
7 |
190 |
0.0001429 |
0.001123 |
593 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
5 |
84 |
0.0001454 |
0.001141 |
594 |
NEURON PROJECTION MORPHOGENESIS |
10 |
402 |
0.0001462 |
0.001145 |
595 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
5 |
85 |
0.0001538 |
0.001201 |
596 |
REGULATION OF CHROMOSOME SEGREGATION |
5 |
85 |
0.0001538 |
0.001201 |
597 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
6 |
135 |
0.0001573 |
0.001224 |
598 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
0.000157 |
0.001224 |
599 |
CELL CYCLE CHECKPOINT |
7 |
194 |
0.0001626 |
0.001263 |
600 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
7 |
195 |
0.0001678 |
0.001301 |
601 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
4 |
47 |
0.0001744 |
0.00135 |
602 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
5 |
88 |
0.0001811 |
0.0014 |
603 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
3 |
19 |
0.0001856 |
0.001432 |
604 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
4 |
48 |
0.0001894 |
0.001457 |
605 |
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
4 |
48 |
0.0001894 |
0.001457 |
606 |
EPITHELIAL CELL PROLIFERATION |
5 |
89 |
0.000191 |
0.001464 |
607 |
MULTICELLULAR ORGANISM REPRODUCTION |
14 |
768 |
0.0001907 |
0.001464 |
608 |
REGULATION OF DNA METABOLIC PROCESS |
9 |
340 |
0.0002002 |
0.001532 |
609 |
PLATELET ACTIVATION |
6 |
142 |
0.0002071 |
0.001582 |
610 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
6 |
143 |
0.0002151 |
0.001641 |
611 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
11 |
505 |
0.0002161 |
0.001645 |
612 |
TONGUE DEVELOPMENT |
3 |
20 |
0.0002175 |
0.001653 |
613 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
4 |
50 |
0.0002221 |
0.001678 |
614 |
FACE DEVELOPMENT |
4 |
50 |
0.0002221 |
0.001678 |
615 |
ENDODERM FORMATION |
4 |
50 |
0.0002221 |
0.001678 |
616 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
50 |
0.0002221 |
0.001678 |
617 |
COVALENT CHROMATIN MODIFICATION |
9 |
345 |
0.0002231 |
0.001682 |
618 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
6 |
144 |
0.0002234 |
0.001682 |
619 |
BONE RESORPTION |
3 |
21 |
0.0002526 |
0.001899 |
620 |
MUSCLE ORGAN DEVELOPMENT |
8 |
277 |
0.0002548 |
0.001912 |
621 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
4 |
52 |
0.0002587 |
0.001935 |
622 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
5 |
95 |
0.0002591 |
0.001935 |
623 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
5 |
95 |
0.0002591 |
0.001935 |
624 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
12 |
606 |
0.0002666 |
0.001988 |
625 |
REGULATION OF SECRETION |
13 |
699 |
0.0002699 |
0.002009 |
626 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
8 |
280 |
0.0002739 |
0.002036 |
627 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
4 |
53 |
0.0002786 |
0.002067 |
628 |
GLAND MORPHOGENESIS |
5 |
97 |
0.0002855 |
0.002114 |
629 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
437 |
0.0002858 |
0.002114 |
630 |
MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
3 |
22 |
0.0002912 |
0.002134 |
631 |
POSITIVE REGULATION OF MUSCLE HYPERTROPHY |
3 |
22 |
0.0002912 |
0.002134 |
632 |
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY |
3 |
22 |
0.0002912 |
0.002134 |
633 |
MEMBRANE ORGANIZATION |
15 |
899 |
0.0002896 |
0.002134 |
634 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
3 |
22 |
0.0002912 |
0.002134 |
635 |
EMBRYONIC PLACENTA MORPHOGENESIS |
3 |
22 |
0.0002912 |
0.002134 |
636 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
7 |
214 |
0.0002961 |
0.002166 |
637 |
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS |
4 |
54 |
0.0002995 |
0.002174 |
638 |
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
5 |
98 |
0.0002994 |
0.002174 |
639 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
152 |
0.000299 |
0.002174 |
640 |
VENTRICULAR SEPTUM DEVELOPMENT |
4 |
54 |
0.0002995 |
0.002174 |
641 |
REGULATION OF CHROMATIN ORGANIZATION |
6 |
152 |
0.000299 |
0.002174 |
642 |
CELL CYCLE ARREST |
6 |
154 |
0.0003207 |
0.002321 |
643 |
AMEBOIDAL TYPE CELL MIGRATION |
6 |
154 |
0.0003207 |
0.002321 |
644 |
REGULATION OF OSTEOBLAST PROLIFERATION |
3 |
23 |
0.0003334 |
0.002409 |
645 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
4 |
56 |
0.0003446 |
0.002475 |
646 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
6 |
156 |
0.0003437 |
0.002475 |
647 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
56 |
0.0003446 |
0.002475 |
648 |
REGULATION OF EXTENT OF CELL GROWTH |
5 |
101 |
0.0003443 |
0.002475 |
649 |
APOPTOTIC MITOCHONDRIAL CHANGES |
4 |
57 |
0.000369 |
0.002645 |
650 |
REGULATION OF HISTONE DEACETYLATION |
3 |
24 |
0.0003794 |
0.002712 |
651 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
3 |
24 |
0.0003794 |
0.002712 |
652 |
PROTEIN ACYLATION |
6 |
159 |
0.0003805 |
0.002715 |
653 |
REGULATION OF DNA REPLICATION |
6 |
161 |
0.0004067 |
0.002898 |
654 |
CEREBRAL CORTEX DEVELOPMENT |
5 |
105 |
0.0004119 |
0.002926 |
655 |
ODONTOGENESIS |
5 |
105 |
0.0004119 |
0.002926 |
656 |
VASCULOGENESIS |
4 |
59 |
0.0004212 |
0.002988 |
657 |
LENS FIBER CELL DIFFERENTIATION |
3 |
25 |
0.0004293 |
0.003017 |
658 |
SPINDLE CHECKPOINT |
3 |
25 |
0.0004293 |
0.003017 |
659 |
FOREBRAIN REGIONALIZATION |
3 |
25 |
0.0004293 |
0.003017 |
660 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
3 |
25 |
0.0004293 |
0.003017 |
661 |
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
3 |
25 |
0.0004293 |
0.003017 |
662 |
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
3 |
25 |
0.0004293 |
0.003017 |
663 |
CARDIAC VENTRICLE DEVELOPMENT |
5 |
106 |
0.0004303 |
0.00302 |
664 |
NEGATIVE REGULATION OF CELL DIVISION |
4 |
60 |
0.0004493 |
0.003139 |
665 |
CELL SUBSTRATE ADHESION |
6 |
164 |
0.0004486 |
0.003139 |
666 |
CHONDROCYTE DIFFERENTIATION |
4 |
60 |
0.0004493 |
0.003139 |
667 |
REGULATION OF CELL CELL ADHESION |
9 |
380 |
0.0004523 |
0.003155 |
668 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
11 |
552 |
0.0004595 |
0.003201 |
669 |
REGULATION OF CELL CYCLE ARREST |
5 |
108 |
0.0004688 |
0.003261 |
670 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
7 |
232 |
0.0004812 |
0.003337 |
671 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
7 |
232 |
0.0004812 |
0.003337 |
672 |
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
3 |
26 |
0.0004832 |
0.003346 |
673 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
5 |
109 |
0.0004891 |
0.003376 |
674 |
RESPONSE TO HYDROGEN PEROXIDE |
5 |
109 |
0.0004891 |
0.003376 |
675 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
4 |
62 |
0.0005093 |
0.003511 |
676 |
REGULATION OF CARTILAGE DEVELOPMENT |
4 |
63 |
0.0005413 |
0.00371 |
677 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
3 |
27 |
0.0005413 |
0.00371 |
678 |
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION |
3 |
27 |
0.0005413 |
0.00371 |
679 |
NEGATIVE REGULATION OF AXON GUIDANCE |
3 |
27 |
0.0005413 |
0.00371 |
680 |
HEMOSTASIS |
8 |
311 |
0.0005505 |
0.003767 |
681 |
REGULATION OF CELL SIZE |
6 |
172 |
0.000577 |
0.003942 |
682 |
REGULATION OF DEFENSE RESPONSE |
13 |
759 |
0.000589 |
0.004019 |
683 |
STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
173 |
0.0005948 |
0.004052 |
684 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
3 |
28 |
0.0006036 |
0.004082 |
685 |
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION |
3 |
28 |
0.0006036 |
0.004082 |
686 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
3 |
28 |
0.0006036 |
0.004082 |
687 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
3 |
28 |
0.0006036 |
0.004082 |
688 |
METANEPHROS MORPHOGENESIS |
3 |
28 |
0.0006036 |
0.004082 |
689 |
RESPONSE TO INTERLEUKIN 1 |
5 |
115 |
0.0006246 |
0.004218 |
690 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
6 |
175 |
0.0006318 |
0.004261 |
691 |
REGULATION OF MICROTUBULE BASED PROCESS |
7 |
243 |
0.0006335 |
0.004266 |
692 |
FEMALE SEX DIFFERENTIATION |
5 |
116 |
0.0006497 |
0.004368 |
693 |
REGULATION OF MEIOTIC NUCLEAR DIVISION |
3 |
29 |
0.0006703 |
0.004494 |
694 |
NEUROBLAST PROLIFERATION |
3 |
29 |
0.0006703 |
0.004494 |
695 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
5 |
117 |
0.0006755 |
0.004516 |
696 |
CELLULAR RESPONSE TO STARVATION |
5 |
117 |
0.0006755 |
0.004516 |
697 |
POSITIVE REGULATION OF NEURON DEATH |
4 |
67 |
0.0006839 |
0.004559 |
698 |
CELLULAR RESPONSE TO DRUG |
4 |
67 |
0.0006839 |
0.004559 |
699 |
CATABOLIC PROCESS |
22 |
1773 |
0.0007137 |
0.004751 |
700 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
4 |
68 |
0.0007234 |
0.004808 |
701 |
REGULATION OF CHEMOTAXIS |
6 |
180 |
0.0007322 |
0.00486 |
702 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR |
3 |
30 |
0.0007416 |
0.004894 |
703 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
3 |
30 |
0.0007416 |
0.004894 |
704 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
3 |
30 |
0.0007416 |
0.004894 |
705 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
3 |
30 |
0.0007416 |
0.004894 |
706 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
9 |
408 |
0.0007518 |
0.004955 |
707 |
NEGATIVE REGULATION OF OSSIFICATION |
4 |
69 |
0.0007644 |
0.005024 |
708 |
POSITIVE REGULATION OF AXONOGENESIS |
4 |
69 |
0.0007644 |
0.005024 |
709 |
RESPONSE TO KETONE |
6 |
182 |
0.0007757 |
0.005091 |
710 |
RESPONSE TO STEROID HORMONE |
10 |
497 |
0.0007783 |
0.0051 |
711 |
SYSTEM PROCESS |
22 |
1785 |
0.0007808 |
0.00511 |
712 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
4 |
70 |
0.000807 |
0.005274 |
713 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
5 |
122 |
0.0008162 |
0.005319 |
714 |
CELLULAR RESPONSE TO INTERFERON GAMMA |
5 |
122 |
0.0008162 |
0.005319 |
715 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
5 |
123 |
0.0008468 |
0.005511 |
716 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
4 |
71 |
0.0008513 |
0.005525 |
717 |
CELL FATE SPECIFICATION |
4 |
71 |
0.0008513 |
0.005525 |
718 |
REGULATION OF PEPTIDE TRANSPORT |
7 |
256 |
0.0008603 |
0.005575 |
719 |
ENDOTHELIAL CELL DIFFERENTIATION |
4 |
72 |
0.0008973 |
0.005804 |
720 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
3 |
32 |
0.0008982 |
0.005804 |
721 |
REGULATION OF SYSTEM PROCESS |
10 |
507 |
0.0009055 |
0.005844 |
722 |
HOMEOSTATIC PROCESS |
18 |
1337 |
0.0009233 |
0.00595 |
723 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
4 |
73 |
0.000945 |
0.006065 |
724 |
G1 DNA DAMAGE CHECKPOINT |
4 |
73 |
0.000945 |
0.006065 |
725 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
4 |
73 |
0.000945 |
0.006065 |
726 |
REGULATION OF HORMONE SECRETION |
7 |
262 |
0.0009846 |
0.006302 |
727 |
EMBRYONIC EYE MORPHOGENESIS |
3 |
33 |
0.0009837 |
0.006302 |
728 |
REGULATION OF DENDRITE MORPHOGENESIS |
4 |
74 |
0.0009944 |
0.006347 |
729 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
4 |
74 |
0.0009944 |
0.006347 |
730 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
6 |
191 |
0.0009964 |
0.006351 |
731 |
PROTEIN ACETYLATION |
5 |
129 |
0.001049 |
0.006675 |
732 |
FOREBRAIN NEURON DEVELOPMENT |
3 |
34 |
0.001074 |
0.006801 |
733 |
ORGAN FORMATION |
3 |
34 |
0.001074 |
0.006801 |
734 |
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
3 |
34 |
0.001074 |
0.006801 |
735 |
NEURAL TUBE PATTERNING |
3 |
34 |
0.001074 |
0.006801 |
736 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
6 |
196 |
0.001138 |
0.007196 |
737 |
DIENCEPHALON DEVELOPMENT |
4 |
77 |
0.001154 |
0.007284 |
738 |
RESPONSE TO MINERALOCORTICOID |
3 |
35 |
0.00117 |
0.007366 |
739 |
INNER EAR RECEPTOR CELL DEVELOPMENT |
3 |
35 |
0.00117 |
0.007366 |
740 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
4 |
78 |
0.001211 |
0.007612 |
741 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
14 |
926 |
0.001215 |
0.007632 |
742 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
8 |
352 |
0.001226 |
0.007685 |
743 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
3 |
36 |
0.001271 |
0.007937 |
744 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
3 |
36 |
0.001271 |
0.007937 |
745 |
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
3 |
36 |
0.001271 |
0.007937 |
746 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
7 |
274 |
0.001275 |
0.007955 |
747 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
5 |
136 |
0.001327 |
0.008266 |
748 |
CIRCADIAN RHYTHM |
5 |
137 |
0.001371 |
0.008527 |
749 |
REGULATION OF RECEPTOR INTERNALIZATION |
3 |
37 |
0.001377 |
0.008531 |
750 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
3 |
37 |
0.001377 |
0.008531 |
751 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
3 |
37 |
0.001377 |
0.008531 |
752 |
METANEPHROS DEVELOPMENT |
4 |
81 |
0.001393 |
0.008606 |
753 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
4 |
81 |
0.001393 |
0.008606 |
754 |
CELL PART MORPHOGENESIS |
11 |
633 |
0.001403 |
0.00866 |
755 |
NEGATIVE REGULATION OF AXON EXTENSION |
3 |
38 |
0.001488 |
0.009149 |
756 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
3 |
38 |
0.001488 |
0.009149 |
757 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
3 |
38 |
0.001488 |
0.009149 |
758 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
5 |
141 |
0.001557 |
0.009557 |
759 |
REGULATION OF CALCIUM ION TRANSPORT |
6 |
209 |
0.00158 |
0.009673 |
760 |
REGULATION OF PEPTIDE SECRETION |
6 |
209 |
0.00158 |
0.009673 |
761 |
POSITIVE REGULATION OF VIRAL TRANSCRIPTION |
3 |
39 |
0.001606 |
0.009791 |
762 |
NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
3 |
39 |
0.001606 |
0.009791 |
763 |
REGULATION OF AXON GUIDANCE |
3 |
39 |
0.001606 |
0.009791 |